These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19790031)

  • 1. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
    Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
    Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
    Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
    J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
    Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
    Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
    Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
    J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression.
    Modarai M; Silva E; Suter A; Heinrich M; Kortenkamp A
    Evid Based Complement Alternat Med; 2011; 2011():213021. PubMed ID: 19906827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma.
    Goey AK; Sparidans RW; Meijerman I; Rosing H; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):41-8. PubMed ID: 21123121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
    Spelman K; Wetschler MH; Cech NB
    J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
    Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
    PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of alkylamides in Echinacea plant materials and dietary supplements by ultrafast liquid chromatography with diode array and mass spectrometric detection.
    Mudge E; Lopes-Lutz D; Brown P; Schieber A
    J Agric Food Chem; 2011 Aug; 59(15):8086-94. PubMed ID: 21702479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS.
    Goey AK; Rosing H; Meijerman I; Sparidans RW; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():151-6. PubMed ID: 22770780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GC-MS analysis of the lipophilic principles of Echinacea purpurea and evaluation of cucumber mosaic cucumovirus infection.
    Hudaib M; Fiori J; Bellardi MG; Rubies-Autonell C; Cavrini V
    J Pharm Biomed Anal; 2002 Aug; 29(6):1053-60. PubMed ID: 12110390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemometric Analysis of Fatty Acid Amide Hydrolase Inhibition by Echinacea Root Extracts.
    Liu R; Burkett K; Rapinski M; Arnason JT; Johnson F; Hintz P; Baker J; Harris CS
    Planta Med; 2021 Apr; 87(4):294-304. PubMed ID: 33296937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
    Matthias A; Gillam EM; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
    Chem Biol Interact; 2005 Jun; 155(1-2):62-70. PubMed ID: 15885678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of CYP3A4 by the multiherbal commercial product Sambucus Force and its main constituents Echinacea purpurea and Sambucus nigra.
    Schrøder-Aasen T; Molden G; Nilsen OG
    Phytother Res; 2012 Nov; 26(11):1606-13. PubMed ID: 22319006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants.
    Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF
    J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-mediated antifungal activity of Echinacea extracts.
    Binns SE; Purgina B; Bergeron C; Smith ML; Ball L; Baum BR; Arnason JT
    Planta Med; 2000 Apr; 66(3):241-4. PubMed ID: 10821050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts.
    Cech NB; Eleazer MS; Shoffner LT; Crosswhite MR; Davis AC; Mortenson AM
    J Chromatogr A; 2006 Jan; 1103(2):219-28. PubMed ID: 16298376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro CYP3A4 metabolism: inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition.
    Hansen TS; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):445-9. PubMed ID: 18947363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activating effects of new alkamides from the roots of Echinacea species.
    Chen Y; Fu T; Tao T; Yang J; Chang Y; Wang M; Kim L; Qu L; Cassady J; Scalzo R; Wang X
    J Nat Prod; 2005 May; 68(5):773-6. PubMed ID: 15921428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.